<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: A fibrinolytic enzyme from Agkistrodon acutus venom, called FIIa, was tested for thrombolytic activity in animals </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Carotid <z:mp ids='MP_0005048'>thrombosis</z:mp> model in rats and rabbits and middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) <z:mp ids='MP_0005048'>thrombosis</z:mp> model in rats were used </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Intravenous administration of FIIa, at a dosage of 0.625 mg/kg, resulted in thrombolysis of carotid <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>However, in middle cerebral artery <z:mp ids='MP_0005048'>thrombosis</z:mp>, the effective thrombolysis dose was 1.25 mg/kg </plain></SENT>
<SENT sid="4" pm="."><plain>When the dosage of FIIa increased, the thrombolytic effect was stronger </plain></SENT>
<SENT sid="5" pm="."><plain>Histological examination of kidney, liver, heart, and lung tissue showed no <z:mp ids='MP_0001914'>hemorrhage</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: It shows that FIIa from Agkistrodon acutus venom is able to solubilize <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> in vivo without <z:mp ids='MP_0001914'>hemorrhage</z:mp> at an effective dose for thrombolysis </plain></SENT>
</text></document>